S&P 500 Index ($SPX)

A key inflation gauge accelerated in December, a sign that many prices are still rising more quickly than most Americans would prefer — and faster than the Federal Reserve’s target of 2% a year

Are Wall Street analysts favoring industrial stock IDEX Corp post its Q4 earnings release this month?

Wall Street inched slightly lower in premarket but was still clinging to gains made earlier in the week as markets await important data on the state of the U.S. economy

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and analysts remain highly upbeat about the stock’s growth potential.

Charles River Laboratories has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Zebra Technologies has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Williams-Sonoma has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

Packaging Corporation has outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.